Reduce Stroke Risks by 17% with DHA
The rising concern around stroke incidents has caught the attention of health professionals worldwide. a concerning 50% rise in stroke prevalence over the last two decades. With strokes now the second leading cause of death globally, the urgency for preventative health strategies has never been greater.
A study featured in the journal Stroke provides valuable insights, highlighting the potential of omega-3 polyunsaturated fatty acids in stroke risk reduction. This extensive research, which followed 183,291 participants for 14.3 years, reveals that higher omega-3 levels are associated with a 17% decrease in stroke risk. Omega-3 are believed to contribute by improving blood flow, reducing triglyceride levels, and providing anti-inflammatory benefits.
In response, Puredia is pleased to introduce our Algia™ 30% Vegan DHA Powder. This product delivers pure DHA without maltodextrin nor starch. For added convenience, our Algia™ Vegan 50% DHA Softgel remains potent for up to three years. Both options are certified halal, kosher, and non-GMO, underscoring our commitment to quality and consumer dietary inclusivity.
Algia™ Vegan DHA
Powder: 10% / 20% / 30% DHA
Oil / Softgel: 40% / 50% DHA
Shelf Life: 2 / 3 years
Strain: Schizochytrium sp.
Low-Temp, Solvent-Free Extracted
TRICAP™ / CrystDry™ Applied
Sustainably & Responsibly Made
This ingredient is certified with: